Integra Lifesciences Holdings Corp (IART) Stock
NSQ · IART
15.22
Fundamentals
Market cap
$1.18B
Price / Earnings ratio
-162.1x
Price / Sales ratio
0.7x
Price / Book ratio
1.1x
Return on assets
-0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Integra Lifesciences Holdings Corp
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
SectorHealthcare
IndustryMedical Devices
Employees4,427
CEODr. Stuart M. Essig Ph.D.
IPO DateAug 16, 1995
HeadquartersPrinceton, NJ
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Stuart M. Essig Ph.D. | CEO, President & Chairman | 1962 |
| Ms. Lea Daniels Knight | Executive VP & CFO | 1972 |
| Mr. Robert T. Davis Jr. | Executive Vice President of Tissue Reconstruction and Distributed Technologies | 1959 |
| Mr. Michael J. McBreen | Executive VP & Chief Commercial Officer | 1966 |
| Mr. Harvinder Pal Singh | Executive VP & President of International Business | 1966 |
| Mr. Jeffrey A. Mosebrook | Senior VP of Finance & Principal Accounting Officer | 1976 |
| Mr. Teshtar Elavia | Corporate VP & Chief Technology Officer | — |
| Christopher Ward | Senior Director of Investor Relations | — |
| Mr. Michael D. Hutchinson | Executive VP, Chief Legal Officer & Secretary | 1971 |
| Laurene Isip | Vice President of Global Corporate Communications & Public Relations | — |
Fundamentals
Valuation
Market cap$1.18B
Price-to-sales ratio0.71
Price-to-book value1.13
Price-earnings ratio-162.10
Return on Equity-48.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio0.71
Earnings Per Share
Earnings Per Share$-0.09
Income Statement
Average volume756,977
EBITDA$-293.28M
1 year high (52w)$20.49
1 year low (52w)$8.70
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



